Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: Detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators - A pilot study

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 5, 2014, Pages 1115-1120

  Bussu, Francesco ^a   Sali, Michela ^a   Gallus, Roberto ^a   Petrone, Gianluigi ^a   Zannoni, Gian Franco ^a   Autorino, Rosa ^a   Dinapoli, Nicola ^a   Santangelo, Rosaria ^a   Vellone, Valerio Gaetano ^a   Graziani, Cristina ^a   Miccichè, Francesco ^a   Almadori, Giovanni ^a   Galli, Jacopo ^a   Delogu, Giovanni ^a   Sanguinetti, Maurizio ^a   Rindi, Guido ^a   Tommasino, Massimo ^b   Valentini, Vincenzo ^a   Paludetti, Gaetano ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; PATHOLOGY; RNA; TUMORS;

DISEASE-SPECIFIC SURVIVALS; HUMAN PAPILLOMAVIRUS; IMMUNOHISTOCHEMISTRY; LOCOREGIONAL CONTROL; METHODS AND MATERIALS; PROGNOSTIC INDICATORS; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

DNA;

FORMALDEHYDE; PARAFFIN; PROTEIN P16; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SPECIFIC SURVIVAL; DNA DETERMINATION; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RISK; MALE; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PILOT STUDY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PARAFFIN EMBEDDING; PILOT PROJECTS; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RNA, VIRAL;

EID: 84904097387     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.04.044     Document Type: Article

References (37)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. J.P. Shah, and W. Lydiatt Treatment of cancer of the head and neck CA Cancer J Clin 45 1995 352 368
3. J.P. Shah, and K.J. Patel Head and neck surgery and oncology 3rd ed. 2003 Mosby St. Louis
4. V. De Vita, T. Lawrence, and S. Rosenberg et al. Rosenberg's cancer: Principles & practice of oncology 8th ed. 2008 Lippincott Williams & Wilkins Philadelphia
5. M.L. Gillison, W.M. Koch, and R.B. Capone et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
6. F. Bussu, M. Sali, and R. Gallus et al. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? Br J Cancer 108 2013 1157 1162
7. N. Stransky, A.M. Egloff, and A.D. Tward et al. The mutational landscape of head and neck squamous cell carcinoma Science 333 2011 1157 1160
8. A.K. Chaturvedi, E.A. Engels, and R.M. Pfeiffer et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol 29 2011 4294 4301
9. L. Hammarstedt, D. Lindquist, and H. Dahlstrand et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer Int J Cancer 119 2006 2620 2623
10. E.M. Sturgis, and P.M. Cinciripini Trends in head and neck cancer incidence in relation to smoking prevalence: An emerging epidemic of human papillomavirus-associated cancers? Cancer 110 2007 1429 1435
11. A.L. Carvalho, I.N. Nishimoto, and J.A. Califano et al. Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database Int J Cancer 114 2005 806 816
12. S. Sethi, R. li-Fehmi, and S. Franceschi et al. Characteristics and survival of head and neck cancer by HPV status: A cancer registry-based study Int J Cancer 131 2012 1179 1186
13. S. Heath, V. Willis, and K. Allan et al. Clinically significant human papilloma virus in squamous cell carcinoma of the head and neck in UK practice Clin Oncol (R Coll Radiol) 24 2012 e18 e23
14. E. Kaminagakura, L.L. Villa, and M.A. Andreoli et al. High-risk human papillomavirus in oral squamous cell carcinoma of young patients Int J Cancer 130 2012 1726 1732
15. P. Lassen, J.G. Eriksen, and A. Krogdahl et al. The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial Radiother Oncol 100 2011 49 55
16. S.B. Edge, D.R. Byrd, and C.C. Compton et al. AJCC cancer staging manual 2010 Springer New York
17. G. Negri, G. Bellisano, and G.F. Zannoni et al. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri Am J Surg Pathol 32 2008 1715 1720
18. V. Bouvard, R. Baan, and K. Straif et al. A review of human carcinogens - part B: Biological agents Lancet Oncol 10 2009 321 322
19. N.F. Schlecht, M. Brandwein-Gensler, and G.J. Nuovo et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer Mod Pathol 24 2011 1295 1305
20. W. Shi, H. Kato, and B. Perez-Ordonez et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma J Clin Oncol 27 2009 6213 6221
21. B.J. Braakhuis, P.J. Snijders, and W.J. Keune et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus J Natl Cancer Inst 96 2004 998 1006
22. M.L. Gillison HPV and prognosis for patients with oropharynx cancer Eur J Cancer 45 Suppl 1 2009 383 385
23. A.R. Kreimer, G.M. Clifford, and P. Boyle et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review Cancer Epidemiol Biomarkers Prev 14 2005 467 475
24. H. Mehanna, T. Beech, and T. Nicholson et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer - systematic review and meta-analysis of trends by time and region Head Neck 35 2013 747 755
25. M.M. Rietbergen, C.R. Leemans, and E. Bloemena et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm Int J Cancer 132 2013 1565 1571
26. A. Nasman, P. Attner, and L. Hammarstedt et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma? Int J Cancer 125 2009 362 366
27. K.K. Ang, J. Harris, and R. Wheeler et al. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
28. A.K. El-Naggar, and W.H. Westra p16 Expression as a surrogate marker for HPV-related oropharyngeal carcinoma: A guide for interpretative relevance and consistency Head Neck 34 2012 459 461
29. G. Franchin, E. Minatel, and C. Gobitti et al. Radiotherapy for patients with early-stage glottic carcinoma: Univariate and multivariate analyses in a group of consecutive, unselected patients Cancer 98 2003 765 772
30. J.G. Spector, D.G. Sessions, and B.H. Haughey et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx Laryngoscope 111 2001 1079 1087
31. G. Almadori, F. Bussu, and G. Cadoni et al. Molecular markers in laryngeal squamous cell carcinoma: Towards an integrated clinicobiological approach Eur J Cancer 41 2005 683 693
32. F.P. Worden, B. Kumar, and J.S. Lee et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: Response and survival positively associated with HPV16 copy number J Clin Oncol 26 2008 3138 3146
33. B. Kumar, K.G. Cordell, and J.S. Lee et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26 2008 3128 3137
34. G. Almadori, F. Bussu, and G. Paludetti Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival? Curr Opin Otolaryngol Head Neck Surg 16 2008 117 126
35. F. Bussu, F.O. Ranelletti, and M. Gessi et al. Immunohistochemical expression patterns of the HER4 receptors in normal mucosa and in laryngeal squamous cell carcinomas: Antioncogenic significance of the HER4 protein in laryngeal squamous cell carcinoma Laryngoscope 122 2012 1724 1733
36. B.J. Braakhuis, R.H. Brakenhoff, and C.J. Meijer et al. Human papilloma virus in head and neck cancer: The need for a standardised assay to assess the full clinical importance Eur J Cancer 45 2009 2935 2939
37. S.J. Smeets, A.T. Hesselink, and E.J. Speel et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen Int J Cancer 121 2007 2465 2472